Cg Asset Management Has Cut Ligand Pharmaceuticals (LGND) Position; Regency Centers (REG) Had 8 Bullish Analysts

September 17, 2017 - By Marie Mckinney

Cg Asset Management Llc decreased Ligand Pharmaceuticals Inc (LGND) stake by 74.25% reported in 2016Q4 SEC filing. Cg Asset Management Llc sold 8,810 shares as Ligand Pharmaceuticals Inc (LGND)’s stock rose 7.66%. The Cg Asset Management Llc holds 3,055 shares with $310,000 value, down from 11,865 last quarter. Ligand Pharmaceuticals Inc now has $2.84B valuation. The stock decreased 0.44% or $0.6 on September 15, reaching $134.7. About 612,203 shares traded or 109.53% up from the average. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has declined 2.87% since September 17, 2016 and is downtrending. It has underperformed by 19.57% the S&P500.

Among 19 analysts covering Regency Centers Corporation (NYSE:REG), 8 have Buy rating, 1 Sell and 10 Hold. Therefore 42% are positive. Regency Centers Corporation had 51 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, January 4 by RBC Capital Markets. Jefferies maintained Regency Centers Corp (NYSE:REG) rating on Monday, May 29. Jefferies has “Hold” rating and $72 target. The company was upgraded on Friday, January 20 by Suntrust Robinson. The stock of Regency Centers Corp (NYSE:REG) has “Buy” rating given on Sunday, August 20 by Jefferies. Jefferies maintained it with “Buy” rating and $7400 target in Monday, July 17 report. The stock of Regency Centers Corp (NYSE:REG) has “Outperform” rating given on Tuesday, January 3 by RBC Capital Markets. Raymond James downgraded the shares of REG in report on Monday, January 9 to “Market Perform” rating. Evercore maintained it with “Hold” rating and $67 target in Tuesday, September 8 report. Zacks upgraded it to “Hold” rating and $71 target in Friday, August 14 report. The rating was upgraded by Jefferies on Friday, June 16 to “Buy”. See Regency Centers Corp (NYSE:REG) latest ratings:

15/09/2017 Broker: Jefferies Old Rating: Buy New Rating: Hold New Target: $67 Downgrade
12/09/2017 Broker: Boenning & Scattergood Rating: Sell New Target: $62.5 Downgrade
11/09/2017 Broker: BMO Capital Markets Rating: Hold New Target: $65.0 Initiate
31/08/2017 Broker: Argus Research Rating: Buy Old Target: $80 New Target: $75 Maintain
22/08/2017 Broker: Robert W. Baird Rating: Buy New Target: $72.0 Maintain
20/08/2017 Broker: Jefferies Rating: Buy New Target: $74.0 Maintain
17/08/2017 Broker: RBC Capital Markets Old Rating: Outperform New Rating: Top Pick Old Target: $78 Upgrade
14/08/2017 Broker: Citigroup Rating: Neutral Old Target: $67 New Target: $70 Maintain
07/08/2017 Broker: Boenning & Scattergood Rating: Hold Maintain
03/08/2017 Broker: RBC Capital Markets Rating: Buy New Target: $70.0000 Maintain

Investors sentiment decreased to 1.09 in 2016 Q4. Its down 1.62, from 2.71 in 2016Q3. It dived, as 36 investors sold Regency Centers Corp shares while 75 reduced holdings. 31 funds opened positions while 112 raised stakes. 107.15 million shares or 5.62% more from 101.44 million shares in 2016Q3 were reported. Menta Lc holds 6,000 shares. Pggm Invs has invested 0.47% in Regency Centers Corp (NYSE:REG). Capstone Asset Management, a Texas-based fund reported 10,207 shares. Lasalle Inv Management Secs Ltd Liability invested in 1.26M shares. Parkside Bankshares holds 0% or 22 shares. Parametric Port Associate Limited Co holds 0% or 9,925 shares in its portfolio. Moreover, Great West Life Assurance Company Can has 0.03% invested in Regency Centers Corp (NYSE:REG) for 151,697 shares. Kemper Master Retirement Trust reported 5,995 shares or 0.26% of all its holdings. State Treasurer State Of Michigan owns 0.02% invested in Regency Centers Corp (NYSE:REG) for 42,100 shares. Robeco Institutional Asset Mngmt Bv invested in 0.04% or 65,399 shares. Moreover, Manufacturers Life Insurance The has 0.01% invested in Regency Centers Corp (NYSE:REG). Ls Inv Ltd Liability Company invested in 0.05% or 10,477 shares. Nomura Asset Mngmt Commerce Ltd holds 0.11% or 86,266 shares in its portfolio. Exane Derivatives holds 0% of its portfolio in Regency Centers Corp (NYSE:REG) for 10,392 shares. Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 36,075 shares or 0.03% of the stock.

Regency Centers Corporation is a real estate investment trust . The company has market cap of $11.06 billion. The Firm is the general partner of Regency Centers, L.P. (the Operating Partnership). It has a 107.31 P/E ratio. The Firm is engaged in the ownership, management, leasing, acquisition and development of retail shopping centers through the Operating Partnership.

Since March 30, 2017, it had 0 insider purchases, and 3 insider sales for $359,504 activity. $49,830 worth of Regency Centers Corp (NYSE:REG) was sold by RAMEY H CRAIG. Shares for $244,520 were sold by SCHWEITZER JOHN C.

The stock decreased 0.73% or $0.48 on September 15, reaching $65. About 1.72 million shares traded or 77.42% up from the average. Regency Centers Corp (NYSE:REG) has declined 19.56% since September 17, 2016 and is downtrending. It has underperformed by 36.26% the S&P500.

Since March 20, 2017, it had 0 insider buys, and 3 insider sales for $6.13 million activity. On Friday, May 12 FOEHR MATTHEW W sold $630,650 worth of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) or 5,621 shares. On Monday, March 20 the insider HIGGINS JOHN L sold $436,400. Another trade for 37,247 shares valued at $4.13 million was sold by Aryeh Jason.

Cg Asset Management Llc increased Apple Inc (NASDAQ:AAPL) stake by 3,403 shares to 13,768 valued at $1.60 million in 2016Q4. It also upped Micron Technology Inc (NASDAQ:MU) stake by 21,200 shares and now owns 310,110 shares. Intercontinentalexchange Inc (NYSE:ICE) was raised too.

Investors sentiment increased to 1.24 in Q4 2016. Its up 0.06, from 1.18 in 2016Q3. It increased, as 23 investors sold LGND shares while 85 reduced holdings. 39 funds opened positions while 91 raised stakes. 22.77 million shares or 1.00% less from 23.00 million shares in 2016Q3 were reported. Texas-based Next Financial Grp has invested 0% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Aqr Management Ltd Liability Co holds 7,750 shares or 0% of its portfolio. Atria Invests Ltd Liability Com reported 2,054 shares. Hsbc Hldgs Plc holds 0.01% or 46,929 shares in its portfolio. The Illinois-based Peak6 Invs LP has invested 0.01% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Stifel Financial Corporation has 0% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) for 6,534 shares. Paradigm Asset Management Co Limited Liability Com stated it has 1,553 shares. Fifth Third Bankshares reported 5,489 shares. Allianz Asset Mgmt Ag owns 0.01% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) for 77,741 shares. Moreover, Fisher Asset Mngmt Limited Liability Company has 0.01% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) for 65,490 shares. Spot Trading Lc has invested 0.02% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Tiaa Cref Mgmt Limited Liability, a New York-based fund reported 60,212 shares. Alliancebernstein Limited Partnership holds 0% or 32,409 shares. Blackrock Japan Co Limited reported 0% stake. Atlantic Tru Group Ltd Limited Liability Company holds 143,571 shares.

Analysts await Ligand Pharmaceuticals Inc. (NASDAQ:LGND) to report earnings on November, 2. They expect $0.37 EPS, up 1,133.33% or $0.34 from last year’s $0.03 per share. LGND’s profit will be $7.80 million for 91.01 P/E if the $0.37 EPS becomes a reality. After $0.54 actual EPS reported by Ligand Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts -31.48% negative EPS growth.

Among 5 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Ligand Pharmaceuticals had 16 analyst reports since September 3, 2015 according to SRatingsIntel. On Friday, December 18 the stock rating was maintained by Roth Capital with “Buy”. The rating was initiated by Stephens with “Overweight” on Wednesday, April 13. On Friday, March 11 the stock rating was maintained by Roth Capital with “Buy”. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Buy” rating by Roth Capital on Thursday, November 19. Deutsche Bank maintained Ligand Pharmaceuticals Inc. (NASDAQ:LGND) rating on Tuesday, August 8. Deutsche Bank has “Hold” rating and $104 target. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Buy” rating by Roth Capital on Wednesday, September 30. TH Capital maintained Ligand Pharmaceuticals Inc. (NASDAQ:LGND) rating on Wednesday, September 30. TH Capital has “Buy” rating and $140 target. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Buy” rating by TH Capital on Thursday, November 19. Deutsche Bank maintained Ligand Pharmaceuticals Inc. (NASDAQ:LGND) rating on Monday, July 17. Deutsche Bank has “Hold” rating and $103 target. On Thursday, September 3 the stock rating was maintained by Roth Capital with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com